July 09, 2026 06:13 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Dalal Street bleeds! Sensex tanks over 1,600 points after Trump declares Iran ceasefire 'over' | 'It's over': Trump says on ceasefire with Iran | PM Modi visits 1,000-year-old Prambanan Temple in Indonesia, shares majestic aerial view of the holy site | Baruipur minor rape-murder case: Key accused Pravash Mondal killed in encounter | 'We have been cheated': Egypt coach slams refereeing after Argentina match sparks controversy | From 0-2 to victory! Argentina stage miraculous comeback amid referee drama to crush Egypt's World Cup dream | Amid outrage over Baruipur, another minor girl allegedly raped in West Bengal | Kerala rain fury: 2 dead, 10 feared trapped as massive Wayanad landslide triggers rescue race | Rick Scott revives Bin Laden issue, questions Pakistan's credibility as Iran mediator | Mbappé vs Paraguayan Senator: Ugly World Cup spat spirals into international controversy
COVID-19
Normal business activities resume in Srinagar post lockdown | Image Credit: UNI

India reports over 48,000 COVID-19 cases, 1,005 deaths in 24 hours

| @indiablooms | Jul 01, 2021, at 04:29 pm

New Delhi/IBNS: In a slight increase in daily cases, India on Thursday reported 48,786 new COVID-19 infections besides registering 1,005 deaths apparently due to the virus in the last 24 hours.

In 24 hours between Wednesday and Thursday mornings, 61,588 COVID-19 patients have recovered, taking the discharge figure to 2,94,88,918.

As per the Health Ministry's data, the country's active cases have decreased to 5,23,257.

The daily recoveries have outnumbered the new infections for the 49th straight day.

The South Asian country, which has centralised its vaccination policy from Jun 21, has so far inoculated 33.57 crore people aged 18 or more.

Giving more strength to India's vaccination drive, native drug making company Zydus Cadila has applied to the country's drug regulator (DCGI) for an emergency use approval of its anti-COVID-19 vaccine, named ZyCov-D.

Four vaccines, Moderna, AstraZeneca's Indian version Covishield, indigenous Covaxin and Russia's Sputnik, have so far been approved by the country for their uses.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.